Home Blog Page 137

‘No discussion’ about banning Maccabi Tel Aviv fans at Stuttgart Europa League match | World News

0
‘No discussion’ about banning Maccabi Tel Aviv fans at Stuttgart Europa League match | World News

Maccabi Tel Aviv fans will be allowed into next week’s Europa League match at Stuttgart, as banning them was not considered, the German club has confirmed to Sky News.

It contrasts with the Israeli club’s fans being excluded from Aston Villa last month after police in Birmingham cited safety threats – a decision now condemned by Europe’s main football supporters’ group.

West Midlands Police chiefs justified the decision on Monday to the Home Affairs Select Committee by referencing racist violence by the Maccabi fans in Amsterdam last year – evidence disputed in part by the Dutch police to Sky News.

Please use Chrome browser for a more accessible video player

5:12

Police face fresh questions over Maccabi football fans ban
We have learned officials in southeast Germany did not consider imposing a ban on Maccabi fans next Thursday for the club’s first Europa League away match since the trip to Birmingham.

“Maccabi Tel Aviv fans can attend this game,” Bundesliga club Stuttgart told Sky News.

“There was no discussion in Stuttgart about excluding away fans – neither among the local authorities nor within the club.”

The municipal council in Stuttgart said that after talks with “all the authorities that deal with public safety, all of them are well prepared and focus on securing public safety”.

 

The decision to allow Israeli fans into Stuttgart’s MHP Arena has been backed by Football Supporters Europe, which is now expressing concern about the moves by authorities in Birmingham to shut out Maccabi fans amid community tensions inflamed by the Israel-Hamas war.

Read more:
Maccabi boss hits out at ‘blatant falsehoods’

Police blame ban on ‘significant hooliganism’

“An away travel ban is always an admission of defeat from the public authorities,” Ronan Evain, executive director of Football Supporters Europe, told Sky News.

“The vast majority of police forces in Europe are perfectly capable of hosting away fans – that’s why only a handful of countries resort to travel bans.

Germany is very experienced in organising high-profile games and never had to resort to such extreme measures.

“We are happy that, contrary to the West Midlands Police, German police opted for an intelligence-informed approach and the protection of fans’ fundamental rights, including freedom of movement.”

Source link

Essential Guide to GLP-1 Agonists for Weight Loss

0



Guide to GLP-1 Agonists: Everything to Know | MyFitnessPal

Type 2 diabetes is one of the most common and well-studied modern diseases. So, new medications to combat this condition are constantly being developed.

One such type of medication is called a glucagon-like peptide 1 (GLP-1) agonist. These meds have become increasingly popular recently because even though GLP-1 receptor agonists were initially developed to treat type 2 diabetes, they began to show a very promising benefit: significant weight loss

If you think you’re a candidate for one of these medicines, read on to learn everything you need to know about GLP-1 agonists for weight loss, how they work, who should take them, their side effects, and more.

What Are GLP-1 Agonists? 

Hormones are your body’s natural messengers. They carry important messages to different organs to keep your body functioning normally. Both insulin and GLP-1 peptide are naturally occurring hormones. 

The food you eat gets broken down into simple sugars (like glucose) in your stomach.

This sugar then enters the bloodstream and travels throughout the body. Insulin directs the sugar from your blood into your cells to be used as energy. 

But when insulin can’t do its job well anymore, the sugar remains in the blood, and you develop type 2 diabetes.

This is why people with diabetes have higher-than-normal blood sugar levels. It’s also why most diabetes medications (including GLP-1 agonists) are targeted towards blood sugar control. 

But like all good planners, your body always has a backup. When insulin starts slacking off (like it does in folks with diabetes), your body sends out the GLP-1 hormone to pick up the slack.

When scientists discovered this smart move, they came up with a way to mimic the body’s actions. Thus, GLP-1 agonists were developed. 

An agonist is any manufactured substance (like a drug or medication) that copies or boosts the actions of a naturally occurring substance (in this case, GLP-1) by stimulating its receptor.

How Does GLP-1 Work? 

GLP-1 is usually produced in the small intestine. It has a four-fold messenger action:

  1. It tells the pancreas to increase insulin secretion to manage your blood sugar levels properly.
  2. It also tells the pancreas not to release hormones like glucagon, which can move glucose from other storage places (like the liver) into the bloodstream.
  3. It tells your stomach to digest the food slowly so that more sugars don’t get added to the bloodstream before insulin can clear them out.
  4. It tells your brain that you’re full and not hungry at all — aka, it decreases hunger and increases satiety. This prevents overeating and keeps you from taking in more food before the previous meal is fully digested. 

This final action has caught the eye of the general public and has pushed GLP-1 agonists—the most well-known being semaglutide—into the limelight, even among people without diabetes.

GLP-1 agonists can decrease your appetite and keep you feeling full all the time. They may help you lose weight, especially if you find portion control challenging.

Does this mean anyone can take GLP-1 drugs to lose weight? Let’s explore the pros and cons of taking these medications for weight loss effects. 

6 Key Considerations of GLP-1 Drugs 

GLP-1 agonists were first approved for use as type 2 diabetes medication by the U.S. Food and Drug Administration (FDA) in 2005. These drugs are usually available in a liquid form, along with a needle and syringe. 

You need to inject them into the fatty tissue under your skin. The most common injection site is the belly, followed by the outer thighs, upper buttocks, and the backs of your arms.

These drugs are usually recommended only after more conventional methods like diet and exercise have failed to produce the desired results.

Even then, GLP-1 agonists aren’t miracle drugs. They should be accompanied by dietary and lifestyle changes for long-term use.

1. Learn who can and cannot take these drugs

To benefit from GLP-1 agonist drugs, your body mass index should either be 30 or higher or be 27 or higher with a health complication like: 

  • Prediabetes or type 2 diabetes 
  • Cardiovascular disease 
  • High blood pressure
  • High cholesterol 
  • Non-alcoholic fatty liver disease
  • Obstructive sleep apnea
  • Polycystic ovarian syndrome

According to MyFitnessPal’s registered dietitian, Stephanie Saletta, you must consult your health care provider before starting this medication. This is because taking any medication comes with certain risks and possible side effects. A good health care provider will help you weigh the risks you face by taking the medication versus the risks of not taking it.

They’ll also factor in the health benefits you’ll receive by taking the medication. These drugs are best suited for individuals who are at health risk related to their weight. For example, if you have obesity, you’re at a higher risk of developing diabetes or heart disease. 

But if you’re NOT at health risk, then these drugs aren’t recommended for you because they put you at unnecessary risk of side effects.

You also shouldn’t take GLP-1s if:

  • You have a personal or family history of thyroid cancer, as they increase the risk of thyroid cancer.
  • You’re pregnant, breastfeeding, or planning to get pregnant.
  • You have severe bowel disease.
  • You’re allergic/sensitive to Semaglutide.

Another thing to consider when opting for GLP-1s is the influence of these drugs on your food consumption.  

For example, GLP-1s impact food intake by quieting food noise and subconsciously getting you to choose less salty, sugary, and fatty foods. This speaks to how powerful your subconscious cues to eat are and the role your brain plays in obesity. 

But this is a double-edged sword because you still need to be conscious and mindful of what you’re eating to ensure you’re eating enough—which is where tracking what you eat comes in.

While taking GLP-1 medications, you need to stay disciplined about making nutritious food choices and tracking your calories to prevent malnutrition and achieve healthy weight loss.

2. Know the GLP-1 drugs available and their effectiveness

Many GLP-1 medications are available on the U.S. market. However, only the following three are currently approved by the FDA for use as weight-loss drugs: 

Semaglutide (Wegovy)

  • Type: injectable
  • Frequency: weekly 
  • Starting dose: 0.25 to 1.7 mg for the first 16 weeks 
  • Maintenance dose: 2.4 mg
  • Efficacy findings:
    1. Manufacturer-sponsored studies of 803 and 1,961 people: average decrease in body weight of 7.9% and 14.9%, respectively, with smaller waists and lower total cholesterol levels, systolic blood pressure, and triglycerides
    2. Research review in 2021: weekly dose of Wegovy led to weight reduction effects in multiple studies

Liraglutide (Saxenda)

Tirzepatide (Zepbound)

  • Dual GLP-1/glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
  • Type: injectable
  • Frequency: weekly 
  • Starting dose: 2.5 mg in 0.5-mL liquid solution for the first 4 weeks 
  • Maintenance dose: 5, 7.5, 10, 12.5, or 15 mg from week 5 (based on treatment response and drug tolerance) 
  • Efficacy findings:
    1. Manufactured-sponsored SURMOUNT-3 trial: total mean weight loss of 26.6% over 84 weeks
    2. Manufactured-sponsored SURMOUNT-4 trial: total mean weight loss of 26% over 88 weeks

3. Keep in mind their potential side effects

GLP-1 agonists come with a long list of potential adverse effects such as:

  1. Digestive system: stomach pain, nausea, vomiting, constipation, diarrhea, heartburn, indigestion, flatulence, bloating, belching, and gastroesophageal reflux
  2. Nervous system: headache, dizziness, fatigue, mood changes, and suicidal behavior or ideation
  3. Low blood sugar and diabetic retinopathy in people with diabetes
  4. Allergic reactions
  5. Drug interactions
  6. Heart rate changes
  7. Gall stones
  8. Pancreatitis 
  9. Kidney damage
  10. Increased risk of thyroid cancer

According to cardiologist and MyFitnessPal scientific advisor Danielle Belardo, MD, most gut-related side effects can be resolved through dietary changes like eating smaller meals, increasing fiber intake, and staying hydrated.

4. Understand the insurance coverage of these drugs

Insurance coverage for GLP-1 agonists like semaglutide depends on several factors, such as the type of medication, plan, provider, and health condition.

GLP-1s are sometimes covered by insurance, but only if deemed medically necessary. For example, some providers cover them if they’re used to treat type 2 diabetes.

Medicare doesn’t cover these drugs for weight loss, but in some states, Medicaid does.

Be sure to check with your provider before starting this drug. Some plans may require prior authorization or a documented diagnosis. You may also need to meet certain health criteria or pay some copayment amount.

Novo Nordisk and Eli Lilly (the manufacturers) offer savings programs for people without insurance coverage.

5. Know the obesity treatment alternatives to GLP-1

Here are some strategies for weight management if GLP-1s aren’t for you:

  • Opt for home-cooked instead of ultra-processed foods.
  • Make small, sustainable changes to nutrition.
  • Add more protein and fiber to your diet.
  • Cut down on high-sugar beverages. Drink more plain water instead.
  • Make sure to get adequate, high-quality sleep.
  • Move your body more — whether it’s through exercise, taking a walk, or even doing chores.
  • In extreme cases, consider other weight loss treatments like surgery or medications that cause weight loss (like phentermine).
  • Seek advice from professionals like a registered dietitian, psychologist, endocrinologist, or physical therapist to receive customized care tailored to your needs.

6. Keep in mind the maximum treatment duration for GLP-1

Research shows that people gain around two-thirds of their lost weight back within a year after stopping GLP-1 supplements. So, these drugs may not be your best choice for long-term weight loss. 

Obesity is considered a chronic condition. Drugs like GLP-1s suppress cravings, increase insulin sensitivity, and mute obesity-promoting pathways in the body. But these effects can be reversed once the drug is stopped. 

In short, GLP-1s can be used for the treatment of obesity but cannot cure it completely. That’s why you need to be mentally prepared to be on GLP-1s potentially for life if you wish to receive permanent benefits.

The Bottom Line: GLP-1s Aren’t Right for Everyone 

Choosing the right drug is dependent on many factors like your health status, drug tolerance, budget, and insurance coverage. Speak to your health care provider before starting any medications. 

At the end of the day, diet and exercise are just as important in a successful weight loss journey. For an easy start, introduce small changes like planning your meals, tracking your calories, or creating an exercise routine.

Originally published June 12, 2024; Updated December 2025

The post Essential Guide to GLP-1 Agonists for Weight Loss appeared first on MyFitnessPal Blog.



Source link

Ultraviolette raises $45 million from Zoho, Lingotto

0
Ultraviolette raises  million from Zoho, Lingotto


Ultraviolette raises $45 million from Zoho, Lingotto

BENGALURU: Bengaluru-based electric motorcycle maker Ultraviolette has raised $45 million in fresh growth capital from Zoho Corporation and European investment firm Lingotto as part of its ongoing Series E round.The company said the funding will be used to scale production and sales of its flagship F77 electric sportbike and the new X‑47 crossover, and to develop upcoming platforms codenamed Shockwave and Tesseract.The investment from Zoho was led by Sridhar Vembu along with Mani and Kumar Vembu, underscoring growing domestic tech‑founder backing for India’s EV ecosystem, while Lingotto adds to a global investor list that already includes TVS Motor, Qualcomm Ventures and TDK Ventures.Ultraviolette has expanded from zero to 30 cities in India in 12 months and plans to reach 100 cities by mid‑2026. It also recently launched the F77 in the UK, taking its European footprint to 12 countries. Co‑founder and CEO Narayan Subramaniam said the Series E momentum will help “build category‑defining electric mobility solutions for India and global markets,” while co‑founder and CTO Niraj Rajmohan said the company is doubling down on battery technology and performance as it scales.





Source link

Saravanan, Tamil cinema’s ‘gentleman producer’, dead | India News

0
Saravanan, Tamil cinema’s ‘gentleman producer’, dead | India News


Saravanan, Tamil cinema’s ‘gentleman producer’, dead

Tamil Cinema Icon, AVM Saravanan, Passes Away At 86

CHENNAI: M Saravanan, the soft-spoken steward of AVM Productions who nurtured Tamil cinema through more than half a century of changes while helping shape careers of its greatest stars like Kamal Haasan, Sivaji Ganesan, Vyjayanthimala and Sivakumar, died Thursday in Chennai of age-related ailments. He was 86.Widely known as the “gentleman producer” of Kollywood, M Saravanan, along with his brothers Kumaran, Murugan, and Balasubramanian, oversaw AVM Productions — India’s oldest film studio — for more than 60 years, producing a string of box-office hits in Tamil, Telugu, Kannada, Malayalam, and Hindi. The studio was founded by his father AV Meiyappan in 1945.Saravanan’s name first appeared in the credits of Mamiyar Mechina Marumagal (1959), a remake of a Marathi film. The movie didn’t do well, but his next, Deiva Piravi, starring Sivaji Ganesan, became a success and was later remade in Hindi as Bindya (starring Balraj Sahni).Over the decades, Saravanan supervised a scintillating catalogue that came to define Tamil cinema. These included Kalathur Kannamma (which introduced Kamal Haasan in 1960), Shivaji Ganesan’s Pava Mannippu (1961), MGR’s Anbe Vaa (1966), Rajinikanth’s Paayum Puli (1983).Tributes poured in on Thursday. Chief minister MK Stalin said Saravanan’s AVM Production had a long bond with the Dravidian movement’s cinematic journey. “The bond grew into a relationship of familial affection…. When I visited the AVM Heritage Museum in May 2023, he warmly reminisced about those cherished memories,” Stalin recalled.Tamil Nadu Governor RN Ravi described Saravanan’s death as a “significant loss to the cultural and creative landscape” of the state.Saravanan is survived by his son MS Guhan, daughter Usha and his brothers.





Source link

Putin says Russia will take Donbas by force or Ukraine’s troops will withdraw

0
Putin says Russia will take Donbas by force or Ukraine’s troops will withdraw


President Vladimir Putin has warned again that Ukrainian troops must withdraw from Ukraine’s eastern Donbas region or Russia will seize it, rejecting any compromise over how to end the war in Ukraine.

“Either we liberate these territories by force, or Ukrainian troops will leave these territories,” he told India Today. Moscow controls some 85% of Donbas.

Ukrainian President Volodymyr Zelensky has ruled out ceding territory.

Putin’s comments come after President Donald Trump said his negotiators discussing a US peace plan believed Russia’s leader “would like to end the war” after Tuesday’s talks in Moscow.

Trump’s envoy Steve Witkoff, who was in Moscow, is due to meet Ukraine’s team in Florida.

Trump said Tuesday’s talks in the Kremlin were “reasonably good”, adding it was too soon to say what would happen as “it does take two to tango.”

The original iteration of the US peace plan proposed to hand over areas of the Donbas still under Ukrainian control to the de facto control of Putin – but the Witkoff team presented a modified version in Moscow.

In his India Today interview ahead of a state visit to Delhi, Putin said he had not seen the new version before his talks with Witkoff and Jared Kushner, Trump’s son-in-law.

“That’s why we had to go over every point, that’s why it took so long,” the Kremlin leader said.

He also said Moscow disagreed with parts of the US plan.

“At times we said that yes, we can discuss this, but to that we can’t agree,” Putin said.

He did not name the sticking points. At least two significant points of contention remain – the fate of Ukrainian territory seized by Russian forces and security guarantees for Ukraine.

Putin’s senior foreign policy adviser and key negotiator Yuri Ushakov earlier said straight after the talks that they produced “no compromise” on ending the war.

Ushakov also implied that the Russian negotiating position had been strengthened thanks to what Moscow said were its recent successes on the battlefield.

Ukraine has repeatedly accused Russia of stalling any ceasefire agreements, saying Moscow is seeking to seize more Ukrainian territory.

Commenting on the Kremlin talks, Ukrainian Foreign Minister Andrii Sybhia said Putin was “wasting the world’s time”.

Ukraine has long insisted on firm security guarantees for Ukraine in any deal.

On Wednesday, Zelensky said “the world clearly feels that there is a real opportunity to end the war” – but negotiations must be “backed by pressure on Russia”, which Kyiv and its European allies accuse of deliberately stalling any ceasefire agreements.

The Ukrainian president said last week his top negotiators had managed to make some key changes in the original US peace plan – seen as strongly favouring Moscow – during talks with an American delegation in Geneva on 23 November.

In a joint statement, US and Ukrainian negotiators said at the time that they had drawn up an “updated and refined peace framework” – but provided no further details.

Top negotiators from Europe – who had voiced concern over the original US plan – were also in the Swiss city last week, meeting separately with the Ukrainian and the US teams.

In a separate development on Thursday, Germany’s Der Spiegel news website said it had obtained a confidential transcript of a conference call in which European leaders expressed concern over the US negotiations.

“There is a possibility that the US will betray Ukraine on the issue of territory without clarity on security guarantees,” French President Emmanuel Macron reportedly said, according to an English transcript of Monday’s conference call.

Meanwhile, German Chancellor Friedrich Merz was quoted as warning that Zelensky had to be “extremely careful in the coming days”.

“They are playing games, both with you and with us,” Merz reportedly said.

Finnish President Alexander Stubb was also quoted as saying: “We mustn’t leave Ukraine and Volodymyr alone with these guys.”

The BBC has not seen the reported transcript.

In response to a Der Spiegel inquiry, France’s Élysée Palace stated that “the president did not express himself in those terms”. The presidential office declined to provide details on how Macron expressed himself, citing confidentiality.

Stubb declined to comment to Der Spiegel, and Merz has not commented on the issue.

The BBC has contacted the White House for comment.

Russia launched a full-scale invasion of Ukraine in February 2022, and Moscow currently controls about 20% of Ukrainian territory.

In recent weeks, Russian troops have been slowly advancing in south-east Ukraine, despite reported heavy combat casualties.



Source link

‘Glorious’ dog the size of a small POLAR BEAR is hoping for a new owner

0
‘Glorious’ dog the size of a small POLAR BEAR is hoping for a new owner


A DOG the size of a small polar bear is hoping for a new owner.

Brody, a six-year-old Pyrenean mountain dog, is 6ft tall on his hind legs — and munches through a kilogram of dog biscuits every day.

Brody, a six-year-old Pyrenean mountain dog, is hoping for a new ownerCredit: SWNS
Brody is 6ft tall on his hind legs and eats a kilogram of dog biscuits every dayCredit: SWNS

Rehoming staff say he loves a head scratch and enjoys sitting on people, despite weighing 66kg.

Brody, also described as “calm, relaxed and friendly”, has had a full de-matting so he can show off his “glorious mountain fluff.”

His last owners handed him in as they were unable to care for him.

Lauren Pickthall, 32, from Animal Concern Cumbria, said: “Stay tuned for updates as he prepares for homing . . . preferably with someone who doesn’t mind being occasionally sat on by a small polar bear.”

DOG DAYS

Xmas list of 12 ‘toxic’ foods to keep away from your dog or risk £2k in vet bills


RUFF TIME

I’m a dog groomer & hate winter staple owners swear by, it ruins your pet’s coat

She added: “Brody is so calm, relaxed, friendly, gentle.

“He is a senior boy now so he only requires a couple of 30-minute walks a dog.

“He loves a tennis ball and being in the company of other people.

“At the moment he is currently being tested around other dogs, people, children, and different environments so we can safely allow him to be adopted by the best new owner when the time comes.”

Brody loves a head scratch and enjoys sitting on people, despite weighing 66kgCredit: SWNS
Brody’s last owners handed him in as they were unable to care for himCredit: SWNS
Brody is described as calm, relaxed, friendly and gentleCredit: SWNS

He will be available for adoption in a couple of weeks.

The new owner should have big dog breed experience, a large outdoor area for him — and a sofa big enough for him to sit on.



Source link

Explained: How UTS differs from traditional tennis

0
Explained: How UTS differs from traditional tennis




Sky Sports’ Karthi Gnanasegaram explains all the differences between UTS to traditional tennis.



Source link

Tonya Stevens, Lattice Semiconductor CAO, sells $194k in stock

0




Tonya Stevens, Lattice Semiconductor CAO, sells $194k in stock



Source link

6 more bodies found, Maoist toll in Bastar shootout hits 18 | India News

0
6 more bodies found, Maoist toll in Bastar shootout hits 18 | India News


6 more bodies found, Maoist toll in Bastar shootout hits 18

RAIPUR: Maoist casualties in Wednesday’s operation by security personnel in Chhattisgarh’s Bastar region rose to 18 after six more bodies, including wanted PLGA commander Vella Modiyam, were retrieved Thursday from the gunfight site along the Dantewada-Bijapur border.Nine of the slain guerrillas, who had a combined bounty of Rs 1.3 crore on their heads, were women. Three security personnel were killed in the fighting. The operation dealt what police said was a decisive blow to the Maoist citadel in Gangaloor. “Vella, aka Mangu Modiyam, was the Maoists’ operational and intelligence commander in Gangaloor and involved in multiple crimes, including the killing of a minor, a student and a villager in Peddakorma,” Bastar IGP Sundarraj said.CM Vishnu Deo Sai lauded the personnel involved in the operation, saying the bravery of the trio killed in action “won’t go in vain”. His deputy Vijay Sharma said Naxalism in Chhattisgarh was now on its “last legs”, with forces engaged in a mop-up across Bastar.





Source link

RaKai breaks silence on Walmart flower incident that led to Twitch ban

0
RaKai breaks silence on Walmart flower incident that led to Twitch ban


RaKai breaks silence on Walmart flower incident that led to Twitch ban

The controversial streamer RaKai has finally spoken out after a viral moment at a Walmart reportedly led to his suspension from Twitch. In the clip that circulated widely online, RaKai was seen picking up a bouquet of flowers and handing it to a woman, apparently without paying. The footage triggered a wave of outrage and speculation, with many calling it shoplifting filmed live. RaKai claimed he instructed an assistant to tell the woman to put the flowers back before she left the store, suggesting the bouquet was not a gift but a mistaken, unpaid item.The incident prompted Twitch to suspend his channel under the “illegal activities” clause, with an initial notice of a two-year ban. The message shown on his dashboard cited a 730-day suspension, which stunned many of his followers and set off debates over streamer ethics and platform enforcement.

What happened with the Walmart clip and Twitch’s response

Twitch’s decision to suspend RaKai followed a string of controversial incidents, but the bouquet incident became the flashpoint. According to reports, the clip showed RaKai putting flowers in a woman’s hands and then appearing to leave without paying. Viewers challenge his intent, arguing that handing over unpaid items already pushes beyond acceptable content boundaries for a live-streaming platform. The ban notice on RaKai’s Twitch account listed “Illegal Activities” as the cause, with the suspension set to expire in December 2027. The decision sparked backlash from fellow streamers and parts of the online community, some questioned whether the punishment fit the act, while others defended Twitch’s move as a necessary stance against public shoplifting. As public pressure mounted, Twitch later clarified that the “two-year” label was a mistake caused by a “visual bug” in the appeals portal. The platform said the error affected only RaKai’s display and no other users; the actual suspension length, conveyed via email, was reportedly shorter. Twitch also confirmed the issue was isolated and has since been corrected. Despite the correction, RaKai’s reputation has taken a hit. Fans remain divided: some accept his explanation and hope for a return, others believe the stunt crossed a moral line and expect lasting consequences.RaKai’s explanation may shed light on his intentions, that the flowers weren’t meant to be a stolen gift, but rather a misjudged moment quickly reversed. Still, the viral clip exposed how live streaming in public spaces can backfire, especially when real-life actions blur into content. Twitch’s swift enforcement, and subsequent correction, underscores the challenges platforms face balancing creator freedom, community standards, and real-world consequences. Regardless of whether the ban’s duration was a bug or not, the incident has reshaped RaKai’s public image and serves as a cautionary tale for streamers about the risks of “IRL content.”Also Read: MrBeast becomes the top US YouTuber for the sixth year in a row





Source link